Literature DB >> 16049488

Molecular recycling within amyloid fibrils.

Natàlia Carulla1, Gemma L Caddy, Damien R Hall, Jesús Zurdo, Margarida Gairí, Miguel Feliz, Ernest Giralt, Carol V Robinson, Christopher M Dobson.   

Abstract

Amyloid fibrils are thread-like protein aggregates with a core region formed from repetitive arrays of beta-sheets oriented parallel to the fibril axis. Such structures were first recognized in clinical disorders, but more recently have also been linked to a variety of non-pathogenic phenomena ranging from the transfer of genetic information to synaptic changes associated with memory. The observation that many proteins can convert into similar structures in vitro has suggested that this ability is a generic feature of polypeptide chains. Here we have probed the nature of the amyloid structure by monitoring hydrogen/deuterium exchange in fibrils formed from an SH3 domain using a combination of nuclear magnetic resonance spectroscopy and electrospray ionization mass spectrometry. The results reveal that under the conditions used in this study, exchange is dominated by a mechanism of dissociation and re-association that results in the recycling of molecules within the fibril population. This insight into the dynamic nature of amyloid fibrils, and the ability to determine the parameters that define this behaviour, have important implications for the design of therapeutic strategies directed against amyloid disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16049488     DOI: 10.1038/nature03986

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  117 in total

1.  Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42.

Authors:  Takeshi Sato; Pascal Kienlen-Campard; Mahiuddin Ahmed; Wei Liu; Huilin Li; James I Elliott; Saburo Aimoto; Stefan N Constantinescu; Jean-Noel Octave; Steven O Smith
Journal:  Biochemistry       Date:  2006-05-02       Impact factor: 3.162

2.  Proper calibration of ultrasonic power enabled the quantitative analysis of the ultrasonication-induced amyloid formation process.

Authors:  Kei-ichi Yamaguchi; Tomoharu Matsumoto; Kazuo Kuwata
Journal:  Protein Sci       Date:  2011-11-22       Impact factor: 6.725

3.  An equilibrium model for linear and closed-loop amyloid fibril formation.

Authors:  Shuo Yang; Michael D W Griffin; Katrina J Binger; Peter Schuck; Geoffrey J Howlett
Journal:  J Mol Biol       Date:  2012-02-24       Impact factor: 5.469

4.  Mapping conformational ensembles of aβ oligomers in molecular dynamics simulations.

Authors:  Seongwon Kim; Takako Takeda; Dmitri K Klimov
Journal:  Biophys J       Date:  2010-09-22       Impact factor: 4.033

5.  Fibril fragmentation in amyloid assembly and cytotoxicity: when size matters.

Authors:  Wei-Feng Xue; Andrew L Hellewell; Eric W Hewitt; Sheena E Radford
Journal:  Prion       Date:  2010-01-29       Impact factor: 3.931

6.  Mass spectrometry and the amyloid problem--how far can we go in the gas phase?

Authors:  Alison E Ashcroft
Journal:  J Am Soc Mass Spectrom       Date:  2010-03-09       Impact factor: 3.109

7.  Globular state in the oligomers formed by Abeta peptides.

Authors:  Seongwon Kim; Takako Takeda; Dmitri K Klimov
Journal:  J Chem Phys       Date:  2010-06-14       Impact factor: 3.488

Review 8.  Amyloid structure and assembly: insights from scanning transmission electron microscopy.

Authors:  Claire Goldsbury; Ulrich Baxa; Martha N Simon; Alasdair C Steven; Andreas Engel; Joseph S Wall; Ueli Aebi; Shirley A Müller
Journal:  J Struct Biol       Date:  2010-09-22       Impact factor: 2.867

Review 9.  Perspectives on NMR in drug discovery: a technique comes of age.

Authors:  Maurizio Pellecchia; Ivano Bertini; David Cowburn; Claudio Dalvit; Ernest Giralt; Wolfgang Jahnke; Thomas L James; Steve W Homans; Horst Kessler; Claudio Luchinat; Bernd Meyer; Hartmut Oschkinat; Jeff Peng; Harald Schwalbe; Gregg Siegal
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

10.  The NatA acetyltransferase couples Sup35 prion complexes to the [PSI+] phenotype.

Authors:  John A Pezza; Sara X Langseth; Rochele Raupp Yamamoto; Stephen M Doris; Samuel P Ulin; Arthur R Salomon; Tricia R Serio
Journal:  Mol Biol Cell       Date:  2008-12-10       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.